Resectability criteria in pancreatic head cancer and outcomes of pancreatoduodenectomy
International Health Sciences Review · 10.07.2026 · 2 (4)
DOI: 10.70164/ihsr.v2i4.200 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 10.07.2026. Verfasst von Gustavo Oliveira Martins da Silva und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pancreatic head ductal adenocarcinoma remains a major clinical challenge because potentially curative treatment depends on accurate selection for pancreatoduodenectomy and effective integration of systemic therapy. This narrative review critically examines contemporary resectability criteria and their relationship with outcomes after pancreatoduodenectomy. Literature was reviewed from major biomedical databases and guideline sources, prioritizing consensus statements, clinical guidelines, randomized trials, systematic reviews and landmark observational studies. Current evidence indicates that resectability should not be reduced to technical operability. Pancreas-protocol computed tomography remains central for assessing tumor contact with the superior mesenteric artery, celiac axis, common hepatic artery, superior mesenteric vein and portal vein, but biological factors, CA 19-9 behavior, suspected nodal or occult metastatic disease, performance status, nutritional reserve and institutional expertise also influence treatment sequencing. Neoadjuvant therapy is strongly supported for borderline resectable disease and selected high-risk resectable cases, whereas routine neoadjuvant therapy for all anatomically resectable pancreatic head cancers remains debated. Pancreatoduodenectomy provides the only potentially curative local treatment, but outcomes depend on margin status, complication control, systemic therapy completion and high-volume multidisciplinary care. Future progress requires standardized definitions, biomarker-guided selection and broader access to specialized pancreatic oncology pathways.
Zitieren
APA
Silva, G. O. M. D., & Coelho, B. T. (2026). Resectability criteria in pancreatic head cancer and outcomes of pancreatoduodenectomy. International Health Sciences Review, 2(4). https://doi.org/10.70164/ihsr.v2i4.200
Vancouver
Silva GOMD, Coelho BT. Resectability criteria in pancreatic head cancer and outcomes of pancreatoduodenectomy. International Health Sciences Review. 2026;2(4). doi:10.70164/ihsr.v2i4.200
BibTeX
@article{Silva2026,
author = {Silva, Gustavo Oliveira Martins da and Coelho, Beatriz Tonini},
title = {Resectability criteria in pancreatic head cancer and outcomes of pancreatoduodenectomy},
journal = {International Health Sciences Review},
year = {2026},
volume = {2},
number = {4},
doi = {10.70164/ihsr.v2i4.200}
}
EUVIMED